Poor old Pacific Edge. Just as investors were daring to think things might get better – kaboom – the world comes crashing down.
The Dunedin-based biotech company, whose products are used in testing for bladder cancer, received confirmation this month its biggest US customer would cease purchases
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
